WW
Therapeutic Areas
RemeGen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Telitacicept (RC18) | Systemic Lupus Erythematosus (SLE) | Approved |
| Disitamab Vedotin (RC48) | HER2+ Gastric Cancer | Approved |
| RC28 | Ophthalmic diseases (e.g., wAMD, DME) | Phase 2/3 |
| RC88 | Solid Tumors (MSLN+) | Phase 1/2 |
| RC148 | Not specified on website | Not specified |
| RC278 | Not specified on website | Not specified |